WallStreetZenWallStreetZen

NASDAQ: RPID
Rapid Micro Biosystems Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their RPID stock forecasts and price targets.

Forecast return on equity

Is RPID forecast to generate an efficient return?

Company
-31.11%
Industry
20.79%
Market
247.92%
RPID's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RPID forecast to generate an efficient return on assets?

Company
-24.8%
Industry
10.71%
RPID is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RPID earnings per share forecast

What is RPID's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.91
Avg 2 year Forecast
-$0.61

RPID revenue forecast

What is RPID's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$34.2M+30.68%
Avg 2 year Forecast
$44.4M+69.81%
RPID's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RPID revenue growth forecast

How is RPID forecast to perform vs Medical Devices companies and vs the US market?

Company
30.68%
Industry
10.48%
Market
19.14%
RPID's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RPID's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RPID vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
RPID$1.41N/AN/A
NVNO$3.52N/AN/A
ICAD$2.41N/AN/A
ICCM$1.18$2.50+111.86%Buy
CTSO$1.02$5.50+439.22%Buy
View Top Medical Device Stocks

Rapid Micro Biosystems Stock Forecast FAQ

What is RPID's earnings growth forecast for 2025-2026?

(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 67.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 59.09%.

Rapid Micro Biosystems's earnings in 2025 is -$48,395,000.On average, 1 Wall Street analyst forecast RPID's earnings for 2025 to be -$39,161,141, with the lowest RPID earnings forecast at -$39,161,141, and the highest RPID earnings forecast at -$39,161,141.

In 2026, RPID is forecast to generate -$26,250,875 in earnings, with the lowest earnings forecast at -$26,250,875 and the highest earnings forecast at -$26,250,875.

If you're new to stock investing, here's how to buy Rapid Micro Biosystems stock.

What is RPID's revenue growth forecast for 2025-2026?

(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual revenue growth rate of 30.68% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.48%, and it is also forecast to beat the US market's average forecast revenue growth rate of 19.14%.

Rapid Micro Biosystems's revenue in 2025 is $26,170,000.On average, 1 Wall Street analysts forecast RPID's revenue for 2025 to be $1,471,770,358, with the lowest RPID revenue forecast at $1,471,770,358, and the highest RPID revenue forecast at $1,471,770,358.

In 2026, RPID is forecast to generate $1,912,440,781 in revenue, with the lowest revenue forecast at $1,912,440,781 and the highest revenue forecast at $1,912,440,781.

What is RPID's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: RPID) forecast ROA is -24.8%, which is lower than the forecast US Medical Devices industry average of 10.71%.

What is RPID's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: RPID) Rapid Micro Biosystems's current Earnings Per Share (EPS) is -$1.12. On average, analysts forecast that RPID's EPS will be -$0.91 for 2025, with the lowest EPS forecast at -$0.91, and the highest EPS forecast at -$0.91. In 2026, RPID's EPS is forecast to hit -$0.61 (min: -$0.61, max: -$0.61).

What is RPID's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: RPID) forecast ROE is -31.11%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.